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Background: The objectives of this paper are to describe the planned implementation and evaluation of the
Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Primary Care (BETTER 2) program
which originated from the BETTER trial. The pragmatic trial, informed by the Chronic Care Model, demonstrated the
effectiveness of an approach to Chronic Disease Prevention and Screening (CDPS) involving the use of a new role, the
prevention practitioner. The desired goals of the program are improved clinical outcomes, reduction in the burden of
chronic disease, and improved sustainability of the health-care system through improved CDPS in primary care.
Methods/design: The BETTER 2 program aims to expand the implementation of the intervention used in the original
BETTER trial into communities across Canada (Alberta, Ontario, Newfoundland and Labrador, the Northwest
Territories and Nova Scotia). This proactive approach provides at-risk patients with an intervention from the
prevention practitioner, a health-care professional. Using the BETTER toolkit, the prevention practitioner
determines which CDPS actions the patient is eligible to receive, and through shared decision-making and
motivational interviewing, develops a unique and individualized ‘prevention prescription’ with the patient. This
intervention is 1) personalized; 2) addressing multiple conditions; 3) integrated through linkages to local, regional,
or national resources; and 4) longitudinal by assessing patients over time. The BETTER 2 program brings together
primary care providers, policy/decision makers and researchers to work towards improving CDPS in primary care.
The target patient population is adults aged 40–65. The reach, effectiveness, adoption, implementation, maintain
(RE-AIM) framework will inform the evaluation of the program through qualitative and quantitative methods. A
composite index will be used to quantitatively assess the effectiveness of the prevention practitioner intervention.
The CDPS actions comprising the composite index include the following: process measures, referral/treatment
measures, and target/change outcome measures related to cardiovascular disease, diabetes, cancer and associated
lifestyle factors.
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Discussion: The BETTER 2 program is a collaborative approach grounded in practice and built from existing work
(i.e., integration not creation). The program evaluation is designed to provide an understanding of issues impacting the
implementation of an effective approach for CDPS within primary care that may be adapted to become sustainable in
the non-research setting.
Keywords: Program evaluation, Chronic disease, Prevention, Screening, Clinical practice guidelinesBackground
Introduction
The purpose of this paper is to describe the planned imple-
mentation and evaluation of the Building on Existing Tools
to Improve Chronic Disease Prevention and Screening in
Primary Care (BETTER 2) program. We will describe the
unique approach the BETTER 2 program takes to address
chronic disease prevention and screening (CDPS) in pri-
mary care settings including the frameworks and evalu-
ation metrics that will be used to measure the effectiveness
of the program in achieving its goals.
The paper is divided into the following three broad
sections: 1) the ‘Background’ section provides an over-
view of CDPS in primary care and discusses the BET-
TER approach to CDPS and the integral role that the
prevention practitioner plays in promoting CDPS. This
section further reviews the effectiveness of the Building
on Existing Tools to Improve Chronic Disease Preven-
tion and Screening in Family Practice (BETTER) trial
and describes the evolution of the BETTER 2 program
including the specific objectives it seeks to accomplish.
2) The ‘Methods/Design’ section explains the prevention
practitioner role and how the BETTER 2 program will
expand and adapt to novel jurisdictions. This section
further includes a description of the planned evaluation
of the BETTER 2 program, which involves qualitative,
quantitative, and health economic components. 3) Lastly,
the ‘Discussion’ section highlights the unique approach
utilized for knowledge integration and the potential out-
comes of the proposed program evaluation.
Background
The prevalence of chronic disease is steadily increasing
[1,2]. These chronic diseases have a substantial impact
on health-care services and many can be prevented. Pri-
mary care is the ideal setting for most CDPS activities.
Regrettably, evidence-based tools and strategies for
CDPS are inconsistently applied in primary care practice.
Barriers to implementing evidence into practice occurs
at multiple levels [3] and are, in part, due to competing
demands on primary care physicians leaving little time
to address CDPS [4,5].
The BETTER trial, a pragmatic randomized con-
trolled trial, previously demonstrated the effectiveness
of an approach to CDPS that involved 1) a clinicalworking group (CWG) which identified and harmo-
nized the evidence for CDPS actions in patients aged
40–65 [6], and 2) an intervention consisting of practice
facilitation at the individual patient-level through the
use of a prevention practitioner (Figure 1) who was in-
ternal to the practice [5,7].
The prevention practitioner was a new role intro-
duced to the primary care practice setting [7]. In the
BETTER trial, the prevention practitioners were health-
care professionals (licensed practical nurse, nurse, diet-
ician, nurse practitioner) who worked with the primary
care providers to develop a comprehensive approach to
evidence-based CDPS within the practice setting [5-7].
Clinicians, researchers, and prevention practitioners with
support from the Center for Effective Practice in Toronto,
Canada participated on the BETTER CWG which identi-
fied the evidence-based clinical guidelines and interven-
tions that were then adapted and incorporated into the
BETTER CDPS tool kit [6]. The tool kit included pa-
tient surveys, prevention visit templates, prevention
prescriptions, a CDPS care map, and patient resources.
The prevention practitioner utilized the BETTER CDPS
tool kit to evaluate patients and, through a process of
shared decision-making, provided the patient with an
individualized prevention prescription and CDPS goals.
The original BETTER trial demonstrated that a pre-
vention practitioner ‘can improve the implementation
of clinically important prevention and screening for
chronic diseases in a cost-effective manner’ [5] in urban
multidisciplinary primary care settings in Alberta and
Ontario, Canada. Further funding was obtained to dis-
seminate, implement, and evaluate the BETTER 2 pro-
gram in heterogeneous populations as well as in rural
and remote settings.Aims of the BETTER 2 program
The overarching aims of the BETTER 2 program are to
improve clinical outcomes, reduce the burden of chronic
disease, and improve the sustainability of the health-care
system through improved CDPS in primary care. The
program targets those chronic diseases that have strong
evidence for prevention and screening, specifically can-
cer, cardiovascular disease, diabetes, and their associated
lifestyle risk factors in patients aged 40–65.
Participants
• Identify a target population (e.g 40-65 yo)
• Invite to attend a visit with the Prevention Practitioner
Preliminary 
Assessment
• Participants complete a health survey before the visit
• Participants' surveys and medical histories are reviewed and eligilbe CDPS manuevers are identified
Prevention 
Practitioner Visit
• Through shared decision making and motivational interviewing a personalized prevention prescription 
tailored to the patient is developed and the patient is provided with a copy
• A follow-up visit time frame is identified
• The participant may be linked to community/local resources (e.g. to help with smoking cessation)
Follow-up
• Reasses participant on follow-up
• Participant completes a health survey at 6 and 12 months after the initial visit
Figure 1 The BETTER chronic disease prevention and screening prevention practitioner intervention.
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following:
1. To introduce the BETTER approach to new
jurisdictions and deepen the impact in the two
original participating provinces
2. To adapt, revise, and tailor the BETTER individual
patient-level CDPS intervention including the survey,
tools, actions, and resources for uptake in a variety
of settings including remote, rural, aboriginal
populations, and disadvantaged populations
3. To synthesize BETTER knowledge products for
translation, dissemination and exchange through the
development of a web resource with updated CDPS
tools, actions, and training resources
4. To evaluate the adapted BETTER intervention using
a mixed methods approach
Methods/design
Intervention (the program)
Experts in research, practice, and policy worked together
to develop the BETTER 2 program with the aim of ad-
dressing CDPS from a policy and practice perspective in-
cluding the needs of the end users, such as health-care
professionals, a key to integrated knowledge translation
[8-11]. Since implementing a new approach and associ-
ated changes are often perceived as challenging [12], a
comprehensive, multilevel approach that engages both
policy makers and practitioners is needed to implement
change successfully [3,13]. The Chronic Care Model is
an integrated approach with multiple and multilevel
strategies that has been demonstrated to be most
effective in addressing chronic disease prevention andmanagement [14-16]. This model was also adopted and
described by Ontario’s Chronic Disease Prevention and
Management Framework [17]. The Chronic Care Model
is the foundational framework that informs the BETTER
2 program (see Figures 2 and 3). The BETTER 2 pro-
gram addresses the knowledge to action gap through
obtaining an understanding of the context-specific prac-
tical wisdom of the primary care providers in diverse set-
tings and facilitates macrolevel knowledge partnerships
between researchers, practitioners, and policymakers [18].
We propose to introduce an intervention that is pro-
active at both the population and an individual patient-
level. The patient intervention consists of a dedicated
prevention visit with the prevention practitioner (see
Figure 1). The prevention practitioners are health pro-
fessionals identified by primary care providers and
trained by the BETTER 2 program to identify at-risk pa-
tients and invite them to a prevention visit. The preven-
tion practitioners further identify local CDPS resources
that are reviewed by the CWG to ensure that they are
evidence based before being integrated into their BET-
TER 2 CDPS tool kits.
The program will collaborate with practice, policy, and
research partners to expand the prevention practitioner
role in Canadian provinces and territories: the Northwest
Territories, Newfoundland and Labrador, and Nova
Scotia, and deepen the impact in the two original par-
ticipating provinces, Alberta and Ontario, through pro-
viding a framework, tools and resources for CDPS in
primary care settings. To accomplish this, the BETTER
2 program, working with partners from each context,
will review, revise, and adapt the original BETTER inter-
vention, including the survey, tools, actions, and resources
Figure 2 Logic model for the BETTER 2 program.
Figure 3 The BETTER 2 mapped onto the chronic disease framework.
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aboriginal populations, and disadvantaged populations.
This will include identifying and cataloging CDPS re-
sources and incentives available to the various communi-
ties engaged in the BETTER 2 program and reviewing the
BETTER CDPS survey and tools to tailor them to the
needs and requirements of those communities.
Presently primary care is focused on acute and
chronic disease management and there is often no spe-
cific individual and too little time committed to CDPS
[7]. The BETTER 2 team will support the prevention
practitioners in their new role and work with them to
conduct an asset mapping activity aimed to identify
local, regional and national resources that the preven-
tion practitioners can integrate into their setting and
role. The BETTER 2 CWG will synthesize evidence-
based CDPS knowledge products for translation, dis-
semination and exchange and provide a web resource
[19] with updated CDPS tools and actions including
training resources such as manuals, webinars and pod-
casts [20]. The team will also oversee and facilitate the
training of the prevention practitioners to develop skills
in CDPS including developing an individualized patient
prescription.
Target population
The target populations include (see Figure 2) [17] the
following:
1. Activated communities and prepared, proactive
community partners including primary care groups
and organizations who will help to facilitate the
BETTER 2 approach to CDPS through dedicating
resources (such as a health-care professional’s time
to take on the role of the prevention practitioner).
Activated communities and partners will be the ones
to support policies and organizational structures and
engage in the BETTER 2 program.
2. Informed, activated individuals and families through
patient participation. The sites will select and
identify at-risk populations such as adult patients of
the participating primary care providers who are
between the ages of 40 and 65, and data will be
obtained from those who provide written informed
consent to participate. We chose this age group
because this is the age group for which most of the
CDPS actions can be applied [5].
3. Prepared proactive practice teams including primary
care providers, researchers, and policy/decision
makers who will work together with the BETTER 2
team to develop a comprehensive source of tools
aimed to transform practice through a patient-level
intervention by a health-care professional within the
practice, the prevention practitioner.Program evaluation using the RE-AIM framework
The BETTER 2 program has developed a logic model
that describes the inputs and the anticipated short-term,
intermediate, and long-term outcomes (see Figure 2).
The program will undergo an evaluation using the RE-
AIM (reach, effectiveness, adoption, implementation,
maintain) framework [21-23]. Most evaluations of health
promotion impact have restricted their focus to one or
two of the five dimensions of quality that are believed to
be important [22]. RE-AIM provides a comprehensive
framework to assess programs that work in the real-
world setting [21,22].
Reach
The reach of the program will be captured through de-
scriptive information. This will include information on
the proportion of the patients approached, who partici-
pated, and who returned for follow-up visits including
the representativeness of those participating, where pos-
sible. In the original BETTER trial, there was a 63% ac-
ceptance rate with a return rate of 81.6% at 7 months
and 10% (46/444) did not attend any visits [5]. In our
rural and more disadvantaged populations, we anticipate
that the proportion of patients accepting and following-
up on the intervention will decrease and the proportion
of patients who do not show up for any visits will
increase.
The reach of the program will include the following:
1. The number of patients approached to participate in
the program (denominator)
2. The number of patients who agree to participate and
who follow-through to actually have a visit with the
prevention practitioner
3. The number of primary care providers/sites
approached and educated about BETTER and the
proportion that have adopted the tools or adapted
the prevention practitioner role into their practices
4. Demographic information (if available) of
participating patients including ethnicity, gender,
age, socioeconomic status, and primary care site
Effectiveness
The effectiveness of the program will be evaluated using
the explicitly defined summary statistics defined below
as well as via the use of a more comprehensive compos-
ite index [5].
Specifically, effectiveness measures will include the
following:
 The proportion of individual CDPS activities
achieved at any point in time. We will identify
specific CDPS action information that we can
capture in the population at six-month intervals
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pressures, alcohol history, smoking status, etc.,
achieved at 0, 6, and 12 months). We will track the
proportion of patients completing these maneuvers
longitudinally at each of these observation points.
 An evaluation of the CDPS achieved using a
composite index [24] developed for CDPS and
adapted from the original BETTER trial [5]. The
composite index is identical in its mathematical
definition to the one used in the original BETTER
trial; however, the items comprising the composite
are different. Informed by the learning experiences
in the BETTER trial, we revised the content to get
better quality data.
The composite index is comprised of process outcome
measures (i.e., monitoring and screening actions), refer-
ral and treatment measures (i.e., appropriate treatment
of out-of-date or off-target actions), and target/change
outcomes (i.e., quantifiable change or improvement ac-
tions). The CDPS actions in each patient eligible to
complete as part of the program are determined at base-
line, and the achievement of these eligible actions is
assessed at follow-up. Where possible, a composite index
for each patient will be calculated at baseline and then
at six-month intervals. If a patient is ineligible (up to
date) for all CDPS maneuvers, then his/her contribution
to the aggregate composite index is non-calculable as
the denominator (the number of eligible items at base-
line) is zero.
The composite index will allow for measures of change
over time, that is, a gross indicator of effectiveness. The
composite index essentially provides an average measure
of effectiveness over all people enrolled in the study, and
suggests the proportion of conditionally eligible maneu-
vers (as defined at baseline) which are achieved at
follow-up. It acts to average over the heterogeneity of
the patients and the maneuvers they are specifically eli-
gible for; hence, it is referred to as a gross measure of ef-
fectiveness. For any given patient, the composite index
can also act as a benchmark of how the patient is doing
with respect to CDPS at any given moment in time. We
will use the composite index as a comprehensive meas-
ure of CDPS to describe the proportion of eligible ac-
tions achieved at six-month intervals, and it will also
allow researchers the opportunity to investigate certain
comparisons of CDPS effectiveness between group fac-
tors, such as jurisdiction, age, sex, etc.
Adoption
Adoption will be assessed by describing the proportion,
characteristics, and representativeness of Canadian set-
tings approached and those willing to participate in the
BETTER 2 program. We will describe the national/provincial/territorial characteristics of the sites, includ-
ing their similarities and differences relative to other
communities in a larger geographic area or region.
Implementation
Implementation of BETTER 2 in the diverse primary care
settings will be captured by detailed description of the
contextual adaptations of the program, the time required
for intervention, and the costs of the intervention. In
addition, the ‘Qualitative Evaluation’ section details the
qualitative approach aimed to capture implementation
information including process, facilitators and barriers,
and contextual issues.
An economic assessment will include the following:
 A description of the implementation cost of the
intervention in various settings including the
amount of time the prevention practitioners spend
with individual patients and the improvement in
CDPS activities achieved by the various patient
populations in the intense intervention groups.
 We will explore the impact of the different levels of
interventions on the costs of the program and
examine patterns in costs over time.
Maintain
We will explore the extent that the program becomes
part of a routine practice and policy over time including
how and if the program can be delivered over the long
term. Most decisions about maintaining a program are
influenced not only by the overall impact of a treatment
but also by its costs [21]. The time and cost of the inter-
vention will be captured as described above.
Evaluation of maintenance will include the following:
 The proportion of primary care providers
introduced to the BETTER 2 approach who use the
BETTER tools/activities calculated at three time
points (see Figure 4, the BETTER 2 timeline).
 The proportion of primary care providers
introduced to the BETTER 2 approach that adapt
the BETTER patient-level intervention, a prevention
practitioner health-care professional, into their prac-
tices calculated at three time points (see Figure 4,
the BETTER 2 timeline).
Qualitative evaluation
A qualitative evaluation will contribute to the overall
program evaluation of the BETTER 2 program and is
aimed at understanding the facilitators and barriers, ben-
efits, and disadvantages of the BETTER approach in var-
ied settings including remote, rural, and disadvantaged
populations. A qualitative evaluation will help to exam-
ine the uptake of the BETTER 2 program by involving
Figure 4 The BETTER 2 timeline.
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health-care providers, administrators, and patients. Data
collection strategies include semi-structured interviews
(one-on-one interviews, focus groups, and patient feed-
back forms) with participants (as identified above) by a
trained researcher at approximately three time periods
throughout the project [25] (see Figure 4, the BETTER 2
timeline).
The goal of the BETTER 2 qualitative evaluation com-
ponent is twofold. One aim is to facilitate and assist with
implementation through the early identification and
intervention of potential barriers to the program. The
secondary goal is to determine the approach’s adaptabil-
ity, sustainability, and perceived impact in primary care
settings. We will capture how the approach was imple-
mented and adapted to various settings, the impact on
patients and practice including any perceived benefits
or disadvantages, the feasibility of the approach, and
how and if the approach will be sustained. We will ex-
plore how the tools/activities were adapted to various
primary care settings including perceptions of how well
these adaptations worked. We will also consider the
contextual factors of the implementation of the pro-
gram, specifically barriers and enablers to program
implementation.
The primary qualitative research questions are
1. What is the impact of BETTER 2 on the health
setting in each community?2. How has BETTER 2 been adapted in each
community?
3. What barriers and enablers are key to
implementation of BETTER 2?
4. How can BETTER 2 be improved?
Theoretical frameworks
The BETTER 2 program involves implementation of a
CDPS approach into various clinical settings which can
be impacted by the health system at various levels, that
is, 1) national and provincial (macro), 2) regional or pro-
gram (meso), and 3) site or clinic (micro) levels [26].
There are numerous models available to inform dissem-
ination and implementation of research [3,27]; however,
many miss important constructs or address only one
level. Upon reviewing several frameworks, we identified
three that could inform our qualitative evaluation at
the macro, meso, and micro health system levels includ-
ing the theoretical domains framework (TDF) [28,29],
the consolidated framework for implementation re-
search (CFIR) [3], and the awareness, desire, know-
ledge, ability and reinforcement (ADKAR) model [30].
The TDF is a comprehensive framework that includes
all of the important constructs of implementation
[28,29]. Since it is inclusive and addresses a large num-
ber of domains (14) and constructs (84), it may not be
the best tool to identify and prioritize the key elements
of the implementation. However, an awareness of the
constructs in the TDF will help ensure that no important
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The CFIR is composed of five major domains that cap-
ture the characteristics of the 1) intervention, 2) outer
setting, 3) inner setting, 4) individuals involved, and 5)
process of implementation [3]. The CFIR framework is a
pragmatic synthesis of several frameworks and models
and will inform the implementation process by identify-
ing key elements in the program implementation in a
systematic way. At the micro level, the qualitative evalu-
ation will be informed by the ADKAR model, a model
that focuses on change processes on the ‘people level’
and is commonly used in business, government, and
community settings [30].
Trial status
The BETTER 2 is a program evaluation and not a re-
search trial. The BETTER 2 program has received ap-
proval for the various research components of the
program evaluation through the University of Alberta,
and St. John’s Newfoundland ethics boards. The program
also has a scientific research license with the Northwest
Territories. The registration number of the original RCT
BETTER trial was ISRCTN07170460.
Discussion
The prevalence of chronic disease is steadily increasing
[1,2], and this epidemic of chronic disease threatens the
sustainability of health-care systems internationally. The
BETTER trial, a pragmatic randomized controlled trial,
demonstrated the effectiveness of a CDPS intervention
that involved prevention practitioners in the primary
care multidisciplinary team settings [5]. The intervention
could be adapted to become sustainable in the non-
research setting. The BETTER 2 program has been
funded to bring together research, practice, and policy,
through an approach to CDPS that includes the end
users. This approach of engaging research, practice, and
policy creates a better fit between the information and the
needs of the users, a key to integrated knowledge transla-
tion [8-11]. This collaborative approach is grounded in
practice and developed from existing work.
Our ultimate long-term outcomes are improved clin-
ical outcomes and reduced burden of chronic disease
through improved early detection of cancers (e.g., breast,
cervical, and colon); lower incidence of cancers through
modification of lifestyle (e.g., lung cancer); and reduction
of chronic disease through prevention (e.g., diabetes,
heart attack, stroke). Cost-effective analyses of the ori-
ginal BETTER trial demonstrated that a prevention prac-
titioner ‘can improve the implementation of clinically
important prevention and screening for chronic diseases
in a cost-effective manner’ [5]. We expect that achieving
these objectives using the BETTER 2 program will lead
to cost savings and therefore improved sustainability ofthe health-care system. The program evaluation as out-
lined in this paper is designed to provide an understand-
ing of the issues impacting the implementation of an
effective approach for CDPS within primary care that
may be adapted to become sustainable in the non-
research setting. The RE-AIM framework informs our
evaluation which includes a composite index to assess
effectiveness in real-world settings [5,21,22,24].
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